WindRose Health Investors Invests in Stellus Rx
December 8, 2025
WindRose Health Investors has made a strategic growth investment in Stellus Rx, a Plano, Texas–based technology-enabled, value-based pharmacy care management platform. The undisclosed transaction will fund Stellus Rx’s expansion of clinical and operational capabilities and the scaling of its platform to serve additional patient populations nationwide.
- Buyers
- WindRose Health Investors, LLC
- Targets
- Stellus Rx
- Industry
- Healthcare Services
- Location
- Texas, United States
- Transaction Type
- Growth capital
Explore More
Related Acquisitions
-
WindRose Health Investors Makes Majority Growth Investment in SubjectWell
April 30, 2024
Healthcare Services
WindRose Health Investors completed a majority growth investment in SubjectWell, the patient-access marketplace that connects motivated patients to clinical trials and treatments. Terms were not disclosed; SubjectWell's management will remain in place and as active shareholders while WindRose provides growth capital to accelerate product development, machine learning and marketplace expansion.
-
WindRose Health Investors Recapitalizes Bluestone Physician Services
April 14, 2021
Healthcare Services
WindRose Health Investors completed an equity recapitalization of Bluestone Physician Services to provide growth capital and support expansion. Bluestone — a provider of on-site primary care, care coordination, and behavioral health services for high-risk, geriatric and disabled patients — will continue to be led by founder Dr. Todd Stivland, who and the executive team retain a significant minority stake.
-
WindRose Health Investors and Francisco Partners Invest in Avalon Healthcare Solutions
January 12, 2026
Healthcare Services
WindRose Health Investors has completed a growth investment in Avalon Healthcare Solutions, a Tampa-based diagnostic intelligence and lab benefits management platform. Existing investor Francisco Partners also made an additional investment to support Avalon’s continued product development and scaling for health plan clients.
-
WindRose Health Investors Recapitalizes Veristat Group Inc.
April 7, 2021
Healthcare Services
WindRose Health Investors completed an equity recapitalization of Veristat Group Inc., a global clinical research organization, with Veristat management retaining a significant minority stake. The investment will provide capital and strategic resources to support Veristat's growth and expansion across clinical development, regulatory affairs, biostatistics, data management and pharmacovigilance; terms were not disclosed.
-
Court Square Capital Partners and WindRose Health Investors Recapitalize Soleo Health
February 3, 2025
Healthcare Services
Court Square Capital Partners and WindRose Health Investors announced a jointly controlled recapitalization of Soleo Health, a Frisco, Texas-based provider of specialty pharmacy and infusion services. The investment will provide capital to scale Soleo's national footprint (26 pharmacies, 30+ infusion suites) and support growth across all 50 states while partnering with the company's founders and management team.
-
WindRose Health Investors Makes Strategic Investment in BPD
August 3, 2022
Marketing & Advertising
WindRose Health Investors, a New York-based healthcare private equity firm, has completed a strategic recapitalization investment in BPD, a Boca Raton-based provider of data-driven marketing services for hospitals and health systems. The founders and management team will continue to lead and remain significant shareholders as WindRose supports BPD's expansion of service offerings and accelerated growth.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.